Literature DB >> 32103283

What's new in cardiogenic shock?

Marc Pineton de Chambrun1, Dirk W Donker1,2, Alain Combes3,4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32103283     DOI： 10.1007/s00134-020-05973-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Norepinephrine, Dopamine, and Vasopressin in Patients with Sepsis and Preexisting or Acute Heart Failure: A Retrospective Cohort Study.

Authors:  Dandan Zhou; Baohua Zhu; Jie Jiang; Guangquan Zhou; Suming Zhou
Journal:  Med Sci Monit       Date:  2021-01-21

2.  Cardioprotective shock management: monitoring and supportive therapies.

Authors:  David Schibilsky; Clement Delmas; Laurent Bonello; Patrick Hunziker
Journal:  Eur Heart J Suppl       Date:  2021-03-27       Impact factor: 1.803

3.  Norepinephrine use in cardiogenic shock patients is associated with increased 30 day mortality.

Authors:  Xin Lu; Xue Wang; Yanxia Gao; Joseph Harold Walline; Shiyuan Yu; Zengzheng Ge; Mubing Qin; Huadong Zhu; Yi Li
Journal:  ESC Heart Fail       Date:  2022-03-14

4.  Assessment of bedside lower limb angiography combined with continuous NIRS monitoring for the detection of lower limb complications of VA-ECMO: an observational monocentric study.

Authors:  Matthieu Koszutski; Mathieu Mattei; Juan Pablo Maureira; Antoine Kimmoun; Bruno Levy
Journal:  Crit Care       Date:  2021-07-31       Impact factor: 9.097
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.